sales@angenesci.com
Login | Register
logo
Structures Search
Home Other Building Blocks Ocaperidone

Ocaperidone

CAS No.:
129029-23-8
Catalog Number:
AG000YST
Molecular Formula:
C24H25FN4O2
Molecular Weight:
420.4793
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5mg
98%
1 week
United States
$210
- +
10mg
98%
1 week
United States
$265
- +
25mg
>98.0%(HPLC)
1 week
United States
$266
- +
Product Description
Catalog Number:
AG000YST
Chemical Name:
Ocaperidone
CAS Number:
129029-23-8
Molecular Formula:
C24H25FN4O2
Molecular Weight:
420.4793
MDL Number:
MFCD00866668
IUPAC Name:
3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2,9-dimethylpyrido[1,2-a]pyrimidin-4-one
InChI:
InChI=1S/C24H25FN4O2/c1-15-4-3-10-29-23(15)26-16(2)19(24(29)30)9-13-28-11-7-17(8-12-28)22-20-6-5-18(25)14-21(20)31-27-22/h3-6,10,14,17H,7-9,11-13H2,1-2H3
InChI Key:
ZZQNEJILGNNOEP-UHFFFAOYSA-N
SMILES:
Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)cccc2C
UNII:
26HUS7139V
Properties
Complexity:
856  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
420.196g/mol
Formal Charge:
0
Heavy Atom Count:
31  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
420.488g/mol
Monoisotopic Mass:
420.196g/mol
Rotatable Bond Count:
4  
Topological Polar Surface Area:
61.9A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
3.3  
Literature
Title Journal
Efficacy of antipsychotic agents at human 5-HT(1A) receptors determined by [3H]WAY100,635 binding affinity ratios: relationship to efficacy for G-protein activation. European journal of pharmacology 20011005
Agonistic properties of alniditan, sumatriptan and dihydroergotamine on human 5-HT1B and 5-HT1D receptors expressed in various mammalian cell lines. British journal of pharmacology 19980401
5-HT1A receptor activates Na+/H+ exchange in CHO-K1 cells through Gialpha2 and Gialpha3. The Journal of biological chemistry 19970321
Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan. Molecular pharmacology 19961201
Properties